Clinical Trial Update: Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating first-line combination therapy of macitentan and tadalafil in newly diagnosed pulmonary arterial hypertension; study terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Macitentan (macitentan)
• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: TERMINATED